icon
icon 11630 SW 97 Street, Miami, Florida 33176, US

Tag: pharmaceutical

APAC Nucleic Acid Therapeutics CDMO Market to Reach $4.04 Billion by 2033: BIS Research

Press Release

In response to the swift progress in nucleic acid therapeutics, pharmaceutical companies have partnered with contract development and manufacturing organizations (CDMOs). This outsourcing trend, coupled with the rising pharmaceutical demand, has led to the global expansion of the nucleic acid […]

Read More>>

Brian Slater and Greg Sephton Join Sterlington to bolster IP and Life Sciences practice areas 

Press Release

New York, September 29, 2023 – Sterlington is proud to announce the strategic addition of two senior partners to its team as Co-Heads of Sterlington’s Intellectual Property (IP) practice. With their extensive experience in IP and life sciences, the appointments […]

Read More>>

Wefight raises 10 million euros to accelerate its growth and expand internationally

Press Release

Paris, September 16, 2021 – French e-health company Wefight is developing free applications to help patients with chronic diseases and cancer. Its objective is to provide them – and those around them – with as much information as possible on […]

Read More>>

Curative Biotechnology, Inc. Names Marc Drimer, CPA to Board of Directors

Press Release

Appointment of Independent Director and Chairman of Audit Committee Expands Financial Expertise on Board Boca Raton, FL, July 20, 2021 — Curative Biotechnology Inc. (OTC: CUBT) (“Curative Biotech” or the “Company”), a development stage biomedical company focused on novel therapies […]

Read More>>

Curative Biotechnology, Inc. Announces Ticker Symbol Change to “CUBT” on OTC Markets

Press Release

Company Appoints Kapil Bharti, Ph.D., and Dimiter Dimitrov, Ph.D. to Scientific and Clinical Advisory Board Boca Raton, FL / iCrowd Newswire/ April 29, 2021 / Curative Biotechnology, Inc.  (OTC: CUBT) a development-stage biomedical company focused on novel therapies for rare diseases, announced today the […]

Read More>>

Connectyx Announces Grant of Exclusive Worldwide License from National Institutes of Health for Repurposing Metformin to Treat Degenerative Eye Disease

Press Release

Boca Raton, FL (Feburary 04, 2021) – Connectyx Technologies Holdings Group, Inc. (OTC: CTYX) (“Connectyx” or the “Company”), a development-stage biomedical company focusing on novel treatments for rare diseases today announced it has entered into an Exclusive Patent License Agreement […]

Read More>>

Kim Bueno Joins Butler Snow’s Austin Office

Press Release

Trial attorney Kim Bueno has joined Butler Snow LLP, expanding the firm’s bench of nationally-recognized first-chair trial attorneys. Bueno represents companies in personal injury actions and complex commercial litigation. Nationally, she is recognized as one of the preeminent pharmaceutical and […]

Read More>>

Connectyx Technologies Holdings Group, Inc. Announces Definitive Agreement with Mid-Atlantic BioTherapeutics, Inc. for Treatment of Symptomatic Rabies

Press Release

Connectyx Technologies Holdings Group, Inc. (OTC: CTYX) (“Connectyx” or the “Company”), a development-stage biomedical company focusing on novel treatments for rare diseases, announced today the Company has signed a definitive agreement with Mid-Atlantic BioTherapeutics, Inc. (MABT) to acquire worldwide rights […]

Read More>>

National Law Review Recognizes IMS Insights Podcast in 2019

Press Release

Pensacola, Fla.  |   IMS ExpertServices has earned national recognition for its thought leadership work through the IMS Insights Podcast series from The National Law Review (NLR) in the 2019 “Go-To Thought Leadership” Awards. NLR announced seventy-five national winners of the […]

Read More>>

ALM Recognizes Shook Partner Hildy Sastre As “Most Effective Lawyer,” Complex Business Litigation

Press Release

MIAMI (Dec. 10, 2019) The Daily Business Review selected Shook, Hardy & Bacon Partner Hildy Sastre as a “Most Effective Lawyer,” Complex Business Litigation. Sastre is among an elite group of trial lawyers with significant first-chair courtroom experience in highly […]

Read More>>

Cookies & Privacy

By using this website, you agree to us using cookies to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
More Information